Skinvisible (SKVI) Stock Price, News & Analysis

Company Overview

Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. It also develops and licenses prescription and over-the-counter products to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.

Key Stats

• Today's Range: $0.17 to $0.17
• 50-Day Range: $0.17 to $0.58
• 52-Week Range: $0.10 to $0.85
• Volume: N/A
• Average Volume: 5,372 shs
• Market Capitalization: $914,356.80
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SKVI Stock Analysis - Frequently Asked Questions

How have SKVI shares performed this year?

Skinvisible's stock was trading at $0.3370 at the beginning of the year. Since then, SKVI stock has decreased by 49.8% and is now trading at $0.1692.
View the best growth stocks for 2025 here.

How were Skinvisible's earnings last quarter?

Skinvisible, Inc. (OTCMKTS:SKVI) announced its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $0.01 million for the quarter.

How do I buy shares of Skinvisible?

Shares of SKVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Skinvisible own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Skinvisible investors own include Angus Energy (ANGS), HEXO (HEXO), Bunker Hill Mining (BHLL), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY) and Aeolus Pharmaceuticals (AOLS).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:SKVI
• CIK: 1085277
• Web: www.skinvisible.com
• Phone: (702) 433-7154
• Fax: 702-433-7192
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.38 million
• Net Margins: -5,920.00%
• Pretax Margin: -5,915.00%
• Return on Equity: N/A
• Return on Assets: -754.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: $20,000.00
• Price / Sales: 45.72
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.99) per share
• Price / Book: -0.09

Miscellaneous

• Outstanding Shares: 5,404,000
• Free Float: 2,540,000
• Market Cap: $914,356.80
• Optionable: Not Optionable
• Beta: 1.76